Circulating H19 has been explored as a diagnostic and prognostic biomarker for other conditions including coronary artery disease [43], multiple myeloma [44], and cancers including bladder and gastric cancer [22, 40, 41, 45, 46]. This evidence concerns the gene H19 and AL amyloidosis.